Author:
Gall Margaret G.,Chen Yiqian,Vieira de Ribeiro Ana Julia,Zhang Hui,Bailey Charles G.,Spielman Derek S.,Yu Denise M. T.,Gorrell Mark D.
Publisher
Public Library of Science (PLoS)
Reference57 articles.
1. Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: a comparative review;CF Deacon;Diabetes Obes Metab,2011
2. Inhibitor selectivity in the clinical application of dipeptidyl peptidase-4 inhibition;MS Kirby;Clin Sci,2010
3. The Dipeptidyl Peptidase IV family in cancer and cell biology;DMT Yu;FEBS J,2010
4. Rationale Behind Targeting Fibroblast Activation Protein–Expressing Carcinoma-Associated Fibroblasts as a Novel Chemotherapeutic Strategy;WN Brennen;Mol Cancer Therapeut,2012
5. Keane FM, Chowdhury S, Yao T-W, Nadvi NA, Gall MG, et al.. (2012) Targeting Dipeptidyl Peptidase-4 (DPP-4) and Fibroblast Activation Protein (FAP) for diabetes and cancer therapy. In: Dunn B, Proteinases as Drug Targets. Cambridge, UK: Royal Society of Chemistry. 119–145.
Cited by
47 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献